Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127120) titled 'Open Label Single Arm Prebiotic Pilot Trial SR001' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sorridi Therapeutics
Condition:
PARKINSON DISEASE (Disorder)
Intervention:
Dietary Supplement: Prebiotic fiber blend
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 1, 2024
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07127120
Published by HT Digital Content Serv...